Omalizumab
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Omalizumab to Accelerate a Symptom-driven Multi-food OIT (NCT04045301) | Philippe Bégin | 2019-11-11 |
| Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions (NCT02968394) | The University Clinic of Pulmonary and Allergic Diseases Golnik | 2014-03-01 |
Track Omalizumab automatically
Every clearance here is in the API, with alerts when new ones post.